News
Merit Medical has gained 41.8% compared with the industry’s 8.8% rise in the past year. Globus Medical, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 14.1%.
Hosted on MSN25d
Reasons to Add Phibro Stock to Your Portfolio Right NowProspering Vaccine Business: PAHC is continuously making investments to expand vaccine manufacturing capacity at several locations ... stocks here. Globus Medical, carrying a Zacks Rank #2 ...
Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...
According to Benzinga Pro, Globus Medical's peer group average for short interest as a percentage of float is 4.39%, which ...
AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March ...
Globus Medical AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first ...
Learn more about whether Globus Medical, Inc. or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed ...
It is hard to get excited after looking at Globus Medical's (NYSE:GMED) recent performance, when its stock has declined 17% over the past three months. It seems that the market might have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results